250mg per Week
At a usage level of 250 mg/week, Sustanon provides basically only a high level of testosterone replacement therapy. Individuals with low testosterone may see a marked improvement, but many with mid-normal or high natural testosterone will see little added effect at this dosage level. Yet, Sustanon is suppressive of the hypothalamus and pituitary at this dosage and will largely shut down natural testosterone production while being used. So, this dosage has relatively little of the benefits of most steroid cycles, but shares the adverse side effect of suppressed testosterone production.
It is very common for bodybuilders to use veterinary steroids for a precontest cycle. Since they are typically assimilated quickly, they do the best work in the shortest amount of time, and are generally out of the system relatively fast in comparison to other ‘roids. And, believe it or not, usually people see fewer side effects when using vet products than when using human ones. Why take anything else? Maybe not ‘why take anything else’, but why not include veterinary steroids, in one form or another, in every cycle? In my mind, veterinary drugs should really be everyone’s choice for extreme condition and definition. They combine well with androgens and other anabolics as well as any drug in the human realm of anabolic steroids. The only problem, these days anyway, is availability. You can find them in Mexico, but you risk fakes, counterfeits, lower quality, or lower dose per ml. You also, of course, face the possibility that you’ll be stopped.
The Ipamorelin Growth Hormone Releasing Peptide Comparison
Ipamorelin is a 3rd generation GHRP behind GHRP-6 and GHRP-2. Ipamorelin has very similar characteristics of GHRP-2: does not have ghrelin’s lipogenic properties and does not promote hunger. Ipamorelin acts synergistically when applied during a Growth Hormone Releasing Hormone (GHRH) pulse or when it is administered along with a GHRH or an analog such as Sermorelin or Modified GRF 1-29 (growth releasing factor, aminos 1-29). The synergy comes both due to the suppression of somatostatin and the fact that ipamorelin increases GH release per-somatotrope, while GHRH increases the number of somatotropes releasing GH. On the other hand, Ipamorelin is similar to GHRP-6 because they both release GH at a very similar strength minus the side effects that of GHRP-6. Both GHRP-6 and GHRP-2 cause a release and an increase in cortisol and prolactin levels, however Ipamorelin only selectively releases GH at any dose. Ipamorelin shares similar functionality to Hexarelin and compared to other peptides, it is a much more stable form of ghrelin and has longer half-life periods of at least two hours long and causes secondary effect by making neurons to become excited.